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Abstract 
The porcine leukocyte protegrins are a family of cysteine-rich antimicrobial peptides the primary structures of which combine features of defensins 
and tachyplesins. We cloned three protegrins from porcine bone marrow mRNA by PCR, including one (PG-4) that was previously unknown. The 
691 bp protegrin cDNAs were > 98.8% identical, and each was surrounded by highly conserved 5' and (in some instances) 3'sequences present in 
structurally dissimilar antimicrobial nd LPS-binding peptides of animal eukocytes. 
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1. Introduction 
Antimicrobial polypeptides play an important role in 
the defense mechanisms of  phagocytes. Unlike the leuko- 
cyte-generated oxidants which also participate in phag- 
ocyte-mediated host defense, the antimicrobial peptides 
and proteins of  leukocytes show marked inter-species 
differences in structure, spectrum and potency. Recent 
reports have shown that porcine, bovine and rabbit leu- 
kocytes ynthesize several structurally diverse antimicro- 
bial peptides on precursors that contain a conserved 
'cathelin' domain [1,2]. Included among these cathelin- 
associated peptides are: porcine PR-39 [3,4], porcine pro- 
tegrin PG-2, [5,6], porcine PMAP-36 [7], rabbit CAP18 
and p15 [8,9], bovine indolicidin [10,11], bovine cyclic 
dodecapeptide [12,13], and bovine Bac5 [14,15]. 
We recently reported the primary sequences of  three 
cysteine-rich antimicrobial peptides (protegrins) that 
were purified from porcine leukocytes [5]. Soon thereaf- 
ter, Storici and Zanetti cloned protegrin PG-2, and re- 
ported that its precursor contained a cathelin domain [4]. 
We now describe the cDNA cloning of  three other prote- 
grins from porcine bone marrow cells: PG-1, PG-3 and 
the newly discovered PG-4. 
corresponded to the 5' regions of PG-2 and PR-39 eDNA and contained 
an EcoRI restriction site. The antisense primer (5'-GTCGTCTAGA 
(C or G) GTTTCACAAGAATTTATTT-3') was complementary to 3' 
ends of PG-2 and PR-39 eDNA immediately preceding their poly(A) 
tails and contained an XbaI restriction site. PCR was carried out in a 
50/al volume using a 1/10 vol. of the above pig cDNA as template, 25 
pmol primers and 2.5 U AmpliTaq DNA polymerase (Perkin Elmer- 
Cetus). The reaction was run for 30 cycles, with 1 min denaturation 
(94°C) and annealing (60"C) steps and a 2 min extension step (72 ° C) 
per cycle. 
2.2. cDNA cloning and sequencing 
The amplified eDNA was fractionated by preparative agarose lec- 
trophoresis and stained with ethidium bromide. The main fragment was 
cut out, digested with EcoRI and XbaI endonucleases (New England 
Biolabs, Beverly, MA), subcloned into a M13mpl8 bacteriophage v c- 
tor, and transformed into E. coli XL1-Blue MRF' competent cells 
(Stratagene, La Jolla, CA). DNA sequencing was performed with a kit 
(US Biochemical Corp., Cleveland, OH). Nucleotide and protein se- 
quences were analyzed with PC-GENE (Intelligenetics, Palo Alto, CA). 
2.3. Northern blots 
10 gg of total RNA was denatured in50% formamide, separated by 
electrophoresis through 1% agarose gels in 0.62 M formaldehyde, and 
blotted onto GeneScreen Plus membranes (DuPont, Boston, MA) by 
capillary transfer. The membrane was baked at 80°C for 2 h, and 
hybridized with 32p-labeled probe in rapid hybridization buffer (Amers- 
ham, Arlington Height, IL). 
3. Results and discussion 
2. Materials and methods 
2.1. cDNA generation and PCR amplification 
Total RNA was extracted from the bone marrow cells of a young red 
Duroc pig with guanidinium thiocyanate [16]. 1 gg of total RNA was 
used to synthesize the first strand eDNA, with 20 pmol oligo(dT) 
primer and 200 U Moloney-murine l ukemia virus (M-MLV) reverse 
transcriptase (Clontech Laboratory, Pale Alto, CA) in a total reaction 
volume of 20/zl. Two PCR primers were prepared. The sense primer 
(5'-GTCGGAATTCATGGAGACCCAGAG (A or G) GCCAG-3') 
*Corresponding author. Fax: (1) (310) 206-8766. 
Storici and Zanetti recently cloned protegrin PG-2 and 
reported that its 5' end contained a cathelin domain that 
was nearly identical to the corresponding re#on in 
PR-39 and several other antimicrobial peptides [6]. Since 
PG-1 and PG-3 closely resemble PG-2 in pr imary struc- 
ture, we expected that their mRNAs  would have similar 
sequences at their 5" and 3' ends. We amplified reverse 
transcribed porcine bone marrow cell RNA,  using an 
upstream primer that corresponded to the 5" ends of  
PG-2 and PR-39 cDNA and a downstream primer 
matching the region immediately preceding the poly(A) 
tail. The resulting =-0.7 kb PCR product was subcloned 
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2 4 6 8 l0 12 14 16 18 
PG - 1 RGG R LCYCR RRF  C V CVGR ( NH 2 ) 
PG - 2 RGG R LCYCR RRF  C I CV  (NH 2 ) 
PG - 3 RGG G LCYCR RRF  C V CVGR (Nil 2 ) 
PG-4  RGG R LCYCR GWI  C F CVGR (G) 
Fig. 1. Primary sequences of protegrins. The amino acid sequences of 
protegrins PG-1, -2 and -3 were previously described [5]. The sequence 
of PG-4 is translated from the cDNA sequences described in this report. 
The C-terminal glycine will probably be represented by an amide in the 
mature peptide, as reported for PG-1, -2 and -3 [17]. 
into M13mpl8, and recombinant plaques were chosen 
for single-strand DNA purification and sequencing. 
These revealed cDNA sequences for three different pro- 
tegrins, two of which corresponded to the previously 
described PG-1 and PG-3 [5], and the other (represented 
by 4 clones) to a novel protegrin, PG-4. Curiously, none 
of the 20 sequenced clones corresponded to PG-2. The 
amino acid sequences of all four protegrins are shown in 
Fig. 1. 
The cDNA sequences of protegrins (PG-1, -3 and -4) 
contained 691 bases, as had previously been shown for 
PG-2 [6]. The nucleotide and deduced amino acid se- 
quences of all 4 protegrins are shown in Fig. 2. PG-1, 
PG-3 and PG-4 each contained complete 447 nucleotide 
open reading frames, with a stop codon (TGA) at posi- 
tion 448, corresponding to a protein with a mass of 
approximately 16.6 kDa, that contained 149 amino acid 
residues. Although PG-1 and PG-3 differed by only one 
nucleotide substitution, this occurred in the mature pep- 
tide region and led to the arginine vs. glycine seen at 
position 4 of the mature peptide (position 134 of the 
precursor). There were 5 nucleotide substitutions in the 
cDNA sequences of PG-1 and PG-4. Four of these were 
located in a region that encoded the mature peptide. All 
were in the first nucleotide of the codon and led to amino 
acid changes in the mature peptide. The fifth difference 
was in 3' untranslated region. 
The cDNA sequences of PG- 1 and PG-2 differed only 
by four nucleotide substitutions. One was situated at 
codon 144 in the mature peptide coding region, and was 
responsible for the single amino acid difference 
(Val~Ile) at position 15 in the mature peptides. Two 
nucleotide substitutions were present in the 3' end un- 
translated region. The final difference replaced the CGA 
found at position 442 in PG-1, -3 and -4 cDNA with a 
stop codon (TGA) in PG-2. This change explains the 
premature truncation of PG-2 (which has only 16 resi- 
dues), relative to other protegrins, which have 18. 
The deduced carboxy-terminal sequence of each prote- 
grin included a carboxy-terminal glycine that was not 
found in mature PG-1, -2 and -3 (PG-4 has not yet been 
isolated). However, since protegrins PG 1-3 are known 
to have amidated carboxy-terminal arginine residues [17] 
the 'missing' glycine residue is the probable donor of 
the C-terminal amide nitrogen atom [18,19]. Northern 
blot analysis of porcine bone marrow RNA by with a 
I0 20 30 40 50 
ATGGAGACCCAGAGAGCCAGCCTGTGCCTGGGGCGCTGGTCACTGTGGCTTCTGCTGCTG 60 
METGluThrG lnArgA laSerLeuCysLeuGlyArgTrpSerLeuTrpLeuLeuLeuLeu 20 
GCACTCGTGGTGCCCTCGGCCAGCGCCCAGGCCCTCAGCTACAGGGAGGCCGTGCTTCGT 120 
A laLeuVa lVa lP roSerA laSerA laG lnA laLeuSerTyrArgGluA laVa lLeuArg  40 
GCTGTGGATCGCCTCAACGAGCAGTCCTCGGAAGCTAATCTCTACCGCCTCCTGGAGCTG 180 
A laVa lAspArgLeuAsnGluGlnSerSerG luA laAsnLeuTyrArgLeuLeuGluLeu  60 
GACCAGCCGCCCAAGGCCGACGAGGACCCGGGCACCCCGAAACCTGTGAGCTTCACGGTG 240 
AspGlnProProLysA laAspGluAspProGlyThrProLysProVa lSerPheThrVa l  80 
AAGGAGACTGTGTGTCCCAGGCCGACCCGGCAGCCCCCGGAGCTGTGTGACTTCAAGGAG 300 
LysGluThrVa lCysProArgProThrArgGlnProProGluLeuCysAspPheLysGlu  100 
AACGGGCGGGTGAAACAGTGTGTGGGGACAGTCACCCTGGATCAGATCAAGGACCCGCTC 360 
AsnGlyArgVa lLysG lnCysVa lG lyThrVa lThrLeuAspGln I leLysAspProLeu  120 
G 3 G 4 
GACATCACCTGCAATGAGGTTCAAGGTGTCAGGGGAGGTCGCCTGTGCTATTGTAGGCGT 420 
Asp I leThrCysAsnGluVa lG lnGlyVa lArgGlyG lyArgLeuCys~rCysArgA=g 140 
Gly 3 GIM 4 
A 2 
T 4 A 4 T 4 T 2 
AGGTTCTGCGTCTGTGTCGGACGAGGATGACGGTTGCGACGGCAGGCTTTCCCTCCCCCA 480 
ArgPheCysVa lCysVa lG lyArgGly - - -  149 
Trp4 I le  4 Phe 4 ___2 
I le  2 
ATTTTCCCGGGGCCAGGTTTCCGTCCCCCAATTTTTCCGCCTCCACCTTTCCGGCCCGCA 540 





Fig. 2. cDNA sequences of protegrins. The PG-1 sequence is shown on the main rows. The other protegfin sequences are shown only where they 
differ from PG-1, and are marked by an identifying superscript ~PG-2, 3 PG-3, 4 PG-4). Predicted mature peptide sequences are shown in boldface. 
The stop codon is indicated by dashes. 
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PG- I  METQRASLCL  GRWSLWLLLL  ALVVPSASAQ ALSYREAVLR AVDRLNEQSS EANLYRLLEL  
PG-2  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG-3  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG-4  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PR-39  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cathe l in  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  E .R  . . . . . . . . . . . . . . . . . . . . . . . . . . .  
C -12  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG- I  DQPPKADEDP GTPKPVSFTV KETVCPRPTR QPPELCDFKE NGRVKQCVGT VTLDQIKDPL  
PG-2  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG-3  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG-4  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PR-39  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NPS IHS.  
Cathe l in  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  - - - - .  . . . . . . . .  NPS IHS.  
C -12  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
PG- I  D ITCNEVQGV RGGRLCYCRR RFCVCVGRG 
PG-2  . . . . . . . . . .  RGGRLCYCRRRFCICVG 
PG-3  . . . . . . . . . .  RGGGLCYCRRRFCVCVGRG 
PG-4  . . . . . . . . . .  RGGRLCYCRG WICFCVGRG 
PR-39  . .S . . . I .S .  RRRPRPPYLP  RPRPPPFFPP  RLPPRIPPGF PPRFPPRFPG KR 
Cathe l in  . .S . . . I .S .  
C-12  . . . . . .  GVRR FPWWWPFLRR PRLRRQAFPP PNVPGPRFPP  PNVPGPRFPP  PNFPGPRFPP  
C-12  PNFPGPRFPP  PNFPGPPFPP  P IFPGPWFPP PPPFRPPPFG PPRFPGRR 
Fig. 3. Alignment of porcine leukocyte peptides. The sequences of protegrin PG-2 [6], protegrins PG-1, -3, -4 (this paper), PR-39 [3,4], cathelin [1,2] 
and clone C-12 [20] are shown. The sequences are compared to PG-1, with identities indicated by dots, differences by the substituted residue, and 
gaps by dashes. Mature peptides are shown in boldface. 
32p-labeled synthetic probe complementary to a sequence 
unique to protegrins revealed a --0.75 kb mRNA that was 
absent when pig alveolar macrophage RNA was probed 
(data not shown), suggesting the differential expression 
of protegrins by granulocytes and mononuclear phag- 
ocytes. As indicated in Fig. 3, the N-terminal prepro- 
regions of protegrins are 100% identical to each other 
(disregarding deletions) and show 93% and 88% identity 
to the corresponding regions in PR-39 and cathelin, re- 
spectively. 
Overall, 89% (618/691) of the nueleotides in PG-1 
eDNA are identical to the corresponding residues in the 
recently described clone C 12 [20]. Fig. 4 aligns the eDNA 
3' to the respective stop codons of these porcine bone 
marrow peptides. Note that the bases occupying posi- 
tions 517-691 in protegrin eDNA are 98.9% identical to 
those found between positions 630-804 in eDNA from 
clone C12. Protegrin eDNA also shows definite, but 
more limited Y homology with eDNA for bovine Bae5 
(Table 1). In contrast to the considerable 5' eDNA ho- 
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
PGI  
C -12  
. . . . . . . . . . . . . . . . . . . . .  CGAGGATGACGGTTGCGACGGCAGGCTTTC -471  
III II l l l l l l l l l l l l l l l] l l l i l l  
- CCTGGTGGTGGCCGTTCCTACGAAGACCACGGTTGCGACGGCAGGCTTTC -446  
- CCTCCCCCAATTTTCCCGGGGCCAGGTTTCCGTCCCCCAATTTTT . . . . . .  516  
I I I I I I I I I I  I fill llIll I IIII IIIIIIII I I 
- CCTCCCCCAAATGTCCCCGGGCCCCGGTTCCCTCCCCCAAATGTCCCCGG -496 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  516  
- GCCCCGGTTCCCTCCCCCAAATTTCCCCGGGCCCCGGTTCCCTCCCCCAA -546  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  516  
- ATTTCCCCGGGCCCCGGTTCCCTCCCCCAAATTTCCCAGGGCCCCCGTTC -596  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  CCGCCTCCACCTTTCCG -533  
I I I I I I I I I I I I I I I I I  
- CCTCCGCCAATTTTCCCTGGGCCGTGGTTCCCTCCGCCTCCACCTTTCCG -646  
- GCCCGCACCATTCGGTCCACCAAGGTTCCCTGGTAGACGGTGAAGGATTT -583  
III I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  
- TCCCCCACCATTCGGTCCACCAAGGTTCCCTGGTAGACGGTC~AAGGATTT -696  
- GCAGGCAACTCACCCAGAAGGCCTTTCGGTACATTAAAATCCCAGCAAGG -633  
l I I l l l l l l l I l l l l l l l l l l l l I l l l l l l l l I l l l l l l l l l l l l l l l l l  
- GCAGGCAACTCACCCAGAAGGCCTTTCGGTACATTAAAATCCCAGCAAGG -746  
- AGACCTAAGCATCTGCTTTGCCCAGGCCCGCATCTGTCAAATAAATTCTT -683  
I I l l l l l t lbl i l J l l l l l l l l l l l i l l l l l l l l l l l l l J l l l i l l l i l l  
- AGACCTAAGCATCTGCTTTGCCCAGGCCCGCATCTGTCAAATAAATTCTT -796  
- GTGAAACC -691  
llilllll 
- GTGAAACC -804  
Fig. 4. A comparison of the sequences 3' to the stop codons of porcine PG-1 and clone C-12 [20]. The TGA signifies the stop codons. 
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Table 1 
Homology of protegrins to other cathelin-associated antimicrobial peptides 
C Zhao et al./FEBS Letters 346 (1994) 285-288 
Region Peptide PG-1 Clone C12 PR-39 Indolicidin Bac 5 Cyclic do- CAP18 
(species) (pig) (pig) (pig) (cattle) (cattle) decapeptide (rabbit) 
(cattle) 
5' Base no. 1-336 3-338 18-353 13-348 15-350 13-348 1-336 
Identical 336/336 334/336 332/336 298/336 291/336 285/336 253/336 
% 100.0 99.4 98.8 88.7 86.7 84.8 75.3 
3' Base no. 517-691  630-804 638-658 529-548 528-661 553-579 No homology 
Identical 175/175 173/175 19/20 19/20 92/134 22/27 
% 100.0 98.9 95.0 95.0 68.7 81.5 
The nucleotide sequences 5' and 3' to the mature protegrin PG-1 were matched with the comparable mRNA regions of the following antimicrobial 
peptides or their precursors: clone C12 [20], PR-39 [3,4], indolicidin [10,11], Bac5 [14,15], cyclic dodecapeptide [12,13] and CAP 18 [8]. Although all 
precursors showed considerable homology to PG-1 in their 5' cathelin-containing re ions, only clone C12 (prophenin) and, to a lesser extent, Bac 5, 
also showed extensive homology in the 3' untranslated region. 
mology between protegrins and these peptides, its 3' ho- 
mology to porcine PR-39, bovine indolicidin and bovine 
cyclic dodecapeptide is limited to the respective polyad- 
enylation signal regions (Table 1). 
We recently purified several peptides that we call 'pro- 
phenins', which proved to be mature products of  the 
'clone C-12' peptide family (Harwig et al., unpublished). 
Although we will describe their structure and properties 
in another communication, the striking 5' and 3' cDNA 
homology of  protegrins and prophenins (e.g. clone C-12) 
cDNA,  suggests that one of  these peptide families prob- 
ably originated by insertion of  its exon into a gene orig- 
inally specifying the other. Because clone C-12 is homol- 
ogous to the protegrin cDNA,  both 3" and immediately 
5' to the bases encoding the protegrin sequence, and 
because protegrin cDNA retains with almost perfect fi- 
delity the bases that encode the last 19 amino acids of  the 
unprocessed prophenin peptide plus the prophenin stop 
codon (TGA), it is virtually certain that prophenin 
gene(s) existed first and the protegrin exon was the inter- 
loper. The almost complete conservation of  the non- 
coding 3' prophenin ucleotides in protegrin cDNA sug- 
gests that this insertional event occurred very recently, 
on an evolutionary time scale. Studies on the genomic 
level should further clarify the evolutionary origins and 
relationships of  these intriguing peptide families. 
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